GEPC News Alert Gepco Ltd. (GEPC) 0.0844 09/26/2014 05:57:46

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gepco Ltd. (GEPC) 0.0844 $GEPC

Gepco, Ltd. Announces Appointment of a New Director
Business Wire - Mon Aug 18, 8:30AM CDT
Gepco, Ltd. (OTCQB: GEPC), announced today that the company has appointed Emilio D. Bacardi to its Board of Directors. Emilio D. Bacardi is currently a Managing Partner of Beverly Wilshire Group Inc., a position which commenced in April 2014. From 1996-2004 Mr. Bacardi served as a Mergers and Acquisitions Director for Lehman Brothers in New York, NY where he acquired extensive experience in mergers and acquisitions as well as fundraising. From 2004-2010 Mr. Bacardi was a Junior Partner at Provident Group in New York, and in such capacity, he was a mergers and acquisitions specialist. From 2010-2014 Mr. Bacardi worked as an independent consultant for various commercial concerns to which he brought his resources and contacts to assist those businesses in doing business in Puerto Rico. Through his connections, he was able to assist his clients in working with governmental agencies in Puerto Rico and also privately to transition those clients to owning and running successful operations, both at the parent and subsidiary level, in Puerto Rico. While he worked with businesses in various fields, he focused primarily on the wind energy sector. Throughout his career he has raised millions of dollars for alternative energy, technology, retail, consumer products, hospitality & entertainment projects as well as funding both private and public companies. His presence within the non-profit world is well known as he regularly participates in fundraising for and organizing events. Mr. Bacardi has a BA degree in Economics from the United States Naval Academy.

Gepco, Ltd. Announces Changes to its Board of Directors and Retention of Advisory Firm as it Prepares to Execute its Luxury Goods Roll-up Strategy
Business Wire - Tue Aug 12, 3:59PM CDT
Gepco, Ltd. (OTCQB: GEPC), announced today that the company has accepted the resignations of three of its board members, Larry Zielke, Ron Loshin and Nic Marlin, as it prepares to initiate a luxury goods roll-up plan. "We are so grateful for the hard work and tireless effort that Larry, Ron and Nic made in forming Gepco and the GemVest division," said Peter Voutsas, Chief Executive Officer. Mr. Voutsas also extended his great appreciation for the departing board members and other shareholders that agreed to return in excess of 100 million shares of the Company's common stock to treasury. "Their contributions formed a strong base for our initial strategy, and subsequently the board members will be focused on building upon the luxury retail brand that is Peter Marco of Beverly Hills," he added.

Gepco, Ltd. Announces Results for Its First Quarter of Diamond Sales
Business Wire - Wed Apr 02, 8:01AM CDT
Gepco, Ltd. (GEPC), announced today that its GemVest subsidiary has generated $605,000 in diamond sales in its first quarter of operations. Sales efforts began on March 17th, which means the company generated these figures in only 14 days of activity. GemVest's net profits were approximately $65,400, or 10.8% of revenues. The 10.8% net profits compare favorably to the industry average of 7.6% as reported by Yahoo Finance: http://biz.yahoo.com/p/742conameu.html

Gepco, Ltd. Announces First Sale by GemVest, Ltd.
Business Wire - Wed Mar 19, 8:01AM CDT
Gepco, Ltd. (OTCQB: GEPC) announced today that its subsidiary, GemVest, Ltd., has made its first sale of an investment-grade diamond.

Gepco, Ltd. Announces New Diamond Acquisition by GemVest, Ltd.
Business Wire - Thu Jan 23, 2:48PM CST
Gepco, Ltd. (OTCQB: GEPC) announced today that its subsidiary, GemVest, Ltd., has purchased a new investment grade diamond.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 80

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 242

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 74

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 25

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: LifeMD Inc Faces Legal Investigation Risks

Updated Category News Views 167

Understanding Recent Developments for LifeMD, Inc. LifeMD, Inc. (NASDAQ: LFMD) is presently facing serious legal scrutiny following an investigation initiated by Faruqi & Faruqi, LLP. This renowned national securities law firm has stepped in to evaluate potential claims on behalf of investors. Investor Engagement Opportunities If you are among the investors who incurred...

Continue Reading
Value Stocks Poised for Growth Amid Market Shifts

Updated Category News Views 119

Value Stocks Set for Growth as Market Dynamics Change The stock market is currently experiencing a notable shift away from tech dominance. In recent months, tech stocks have faced challenges, raising questions about the potential revival of value stocks. This change in market sentiment is particularly evident in the impressive performance of the Value ETF, which has...

Continue Reading
EXEL Industries Reveals Key Share and Voting Rights Insights

Updated Category News Views 57

EXEL Industries Overview EXEL Industries is a prominent French Société Anonyme, with a robust share capital amounting to €16,969,750. The company has established a significant presence in the industry through its high standards and innovative products. Understanding Share Capital and Voting Rights On August 31, 2024, EXEL Industries provided updated insights regarding...

Continue Reading
Protective Life Corporation Strengthens Portfolio with Acquisition

Updated Category News Views 112

Protective Life Corporation Strengthens Its Portfolio In a significant development for Protective Life Corporation, the company has successfully completed the acquisition of ShelterPoint Group, Inc. Shielded under the corporate umbrella of Dai-ichi Life Holdings, Inc., Protective Life Corporation continues to solidify its position in the employee benefits industry. This...

Continue Reading
Safeguarding Your Personal Data in a Digital Health Era

Updated Category News Views 160

Understanding the Importance of Data Security in Health Tech As the holiday season approaches, consumers are excitedly purchasing various digital health tools such as fitness trackers, meditation apps, and smart scales. While these innovations can greatly enhance our wellness journey, they also raise significant concerns regarding the security of our personal data. Expert...

Continue Reading